AIMC Topic: Disease Management

Clear Filters Showing 21 to 30 of 106 articles

Use of Artificial Intelligence Including Multimodal Systems to Improve the Management of Cardiovascular Disease.

The Canadian journal of cardiology
The rising prevalence of cardiovascular disease presents an escalating challenge for current health services, which are grappling with increasing demands. Innovative changes are imperative to sustain the delivery of high-quality patient care. Recent ...

Transforming Hypertension Diagnosis and Management in The Era of Artificial Intelligence: A 2023 National Heart, Lung, and Blood Institute (NHLBI) Workshop Report.

Hypertension (Dallas, Tex. : 1979)
Hypertension is among the most important risk factors for cardiovascular disease, chronic kidney disease, and dementia. The artificial intelligence (AI) field is advancing quickly, and there has been little discussion on how AI could be leveraged for...

Managing a patient with uveitis in the era of artificial intelligence: Current approaches, emerging trends, and future perspectives.

Asia-Pacific journal of ophthalmology (Philadelphia, Pa.)
The integration of artificial intelligence (AI) with healthcare has opened new avenues for diagnosing, treating, and managing medical conditions with remarkable precision. Uveitis, a diverse group of rare eye conditions characterized by inflammation ...

Applications of spatial transcriptomics and artificial intelligence to develop integrated management of pancreatic cancer.

Advances in cancer research
Cancer is a complex disease intrinsically associated with cellular processes and gene expression. With the development of techniques such as single-cell sequencing and sequential fluorescence in situ hybridization (seqFISH), it was possible to map th...

Advancing precision rheumatology: applications of machine learning for rheumatoid arthritis management.

Frontiers in immunology
Rheumatoid arthritis (RA) is an autoimmune disease causing progressive joint damage. Early diagnosis and treatment is critical, but remains challenging due to RA complexity and heterogeneity. Machine learning (ML) techniques may enhance RA management...

Role of Artificial Intelligence in Improving Syncope Management.

The Canadian journal of cardiology
Syncope is common in the general population and a common presenting symptom in acute care settings. Substantial costs are attributed to the care of patients with syncope. Current challenges include differentiating syncope from its mimickers, identify...

Artificial intelligence in therapeutic management of hyperlipidemic ocular pathology.

Experimental eye research
Hyperlipidemia has many ocular manifestations, the most prevalent being retinal vascular occlusion. Hyperlipidemic lesions and occlusions to the vessels supplying the retina result in permanent blindness, necessitating prompt detection and treatment....

Machine learning-driven diagnostic signature provides new insights in clinical management of hypertrophic cardiomyopathy.

ESC heart failure
AIMS: In an era of evolving diagnostic possibilities, existing diagnostic systems are not fully sufficient to promptly recognize patients with early-stage hypertrophic cardiomyopathy (HCM) without symptomatic and instrumental features. Considering th...

The scope of artificial intelligence in retinopathy of prematurity (ROP) management.

Indian journal of ophthalmology
Artificial Intelligence (AI) is a revolutionary technology that has the potential to develop into a widely implemented system that could reduce the dependence on qualified professionals/experts for screening the large at-risk population, especially i...